Ashdot Ya’acov Ichud, Israel, September 9, 2025 — LOG Pharma Primary Packaging, a leading global provider of innovative packaging solutions for the pharmaceutical industry, will be exhibiting sustainable and complete packaging solutions, at CPHI Frankfurt 2025, taking place on October 28–30.
At Stand 8.0D74, Zone Packaging, LOG will present its latest innovations. This will include the groundbreaking Eco line of barrier bottles and a fully integrated closure solution, offering drug manufacturers a complete, compliant, and sustainable packaging system of bottles and caps at the same facility from a single trusted source.
At CPHI, LOG will be highlighting its core mission: building confidence through high-performance pharmaceutical packaging. With a strong emphasis on sustainability, innovation, and regulatory excellence, LOG is enabling pharmaceutical companies to meet today’s performance and environmental goals without compromise.
One of the highlights at this year’s event is LOG’s Eco line, a next-generation barrier bottle developed with pharma-grade HEALTH+ resins, powered by Dow. These lightweight bottles offer enhanced moisture and oxygen protection, while reducing material usage by up to 30 percent. Eco line helps pharmaceutical manufacturers lower costs and meet growing environmental expectations, without sacrificing product integrity.
“With environmental sustainability rising in importance across all industries, the pharmaceutical sector is taking active steps to shrink its ecological footprint,” said Ofer Carmon, LOG CEO. “Our Eco barrier line demonstrates that it is possible to combine barrier performance and sustainability.”
Also on display will be LOG’s complete packaging solutions. Responding to industry demand for greater compatibility, LOG produces both bottles and matching closures in-house with full conformity with ISO 8317:2015 and US16 CFR 1700.20 standards. The combined solution is already in use by several leading global pharmaceutical companies.
All LOG products are developed with strict adherence to both EU and FDA requirements, ensuring peace of mind for regulatory and quality teams.
